School of Pharmacy and Medical Sciences, Sansom Institute for Health
Research, University of South Australia, Adelaide, 5001, Australia Background and Aim: Influenza A viruses have the ability to cause severe respiratory tract infections that can be lethal when the virus spreads to the alveolar space, which is more commonly observed with high pathogenic influenza virus strains. The excessive generation of reactive oxygen species (ROS), regardless of the subcellular source can indiscriminately exacerbate lung inflammation and injury during influenza virus infections. Our previous work demonstrates that influenza A viruses, irrespective of strain, causes a substantial burst of ROS production via NOX2 oxidase that occurs in endosomes. Evidently, targeting this process with an endosomal NOX2 oxidase inhibitor (cholestenol conjugated gp91ds-TAT (Cgp91)) improved overall morbidity in mice infected with a low pathogenic strain of influenza A virus (IAV) (1). The aim of this present study was to determine the effect of Cgp91 treatment on the lung pathology induced by a highly pathogenic strain of IAV.
Methods: Male C57Bl/6J mice were treated daily via intranasal administration with Cgp91 (0.2mg/kg) or DMSO (2%; control) over a 4-day period. Mice were infected with the PR8 (H1N1; 500 PFUs) strain of IAV or PBS control, one-day post initial drug treatment and analysed at day 3 post-infection. Bronchoalveolar lavage (BAL) fluid collected from mice was used to assess airway inflammation. Histopathological analysis of lung was assessed using H&E stain and scored for alveolitis, inflammatory cell infiltrate and peribronchiolar inflammation. Superoxide generation in the BAL was measured using L-012 enhanced chemiluminescence and changes in cytokine and viral mRNA expression in the lung were quantified using real-time QPCR.
Results: Cgp91 treatment significantly (P < 0.05) reduced airway inflammation, neutrophil extravasation, and pulmonary inflammation as measured by the degree of alveolitis, inflammatory cell infiltrate and peribronchiolar inflammation. Furthermore, Cgp91 attenuated ROS production in inflammatory cells isolated from the BAL and influenza viral mRNA expression in the lung of PR8-infected mice.
Conclusion:
The spatial targeting of this pathogenic process by inhibiting NOX2 in endosomal compartments with Cgp91 could be used as a potential treatment strategy against highly pathogenic IAV strains. School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA Background and Aims: Lung cancer continues to be the leading cause of cancer death in the United States, with most cancers diagnosed in former smokers. While avoidance of tobacco abuse is clearly the strongest deterrent of lung cancer, chemoprevention in former smokers may be a more effective intervention than treatment of established lung cancers. A phase II trial found that the oral prostacyclin analogue iloprost improves endobronchial dysplasia in former smokers but not current smokers. We hypothesize that epigenetic mechanisms mediate the chemopreventive effects of iloprost and could be markers of iloprost activity. Frizzled 9 (Fzd9) is required for iloprost activity in vitro and has reduced expression with cigarette smoke exposure and in NSCLC.
Results: We detected increased promoter hypermethylation of Fzd9 in lung cancer cell lines, suggesting a role for cigarette smoke induced methylation in the effectiveness of iloprost. We identified reduced Fzd9 3'UTRluciferase activity in vitro with exposure to cigarette smoke. Iloprost reduces the expression of several miRNA that are increased by cigarette smoke in bronchial epithelial cells, pointing to a role for miRNA in regulation of Fzd9 expression and iloprost activity. We identified a panel of lncRNA with altered expression induced by cigarette smoke exposure and reversed by iloprost in vitro. In particular, the conserved lncRNA GAS5 is similarly altered in vitro, in mice exposed to tobacco carcinogens or increased levels of prostacyclin, and in progressive and regressive primary bronchial dysplastic cells.
Conclusions:
This work characterizes epigenetic regulation in smoke and iloprost exposed lung epithelial cells, offering potential mechanisms for iloprost action and markers to monitor response during iloprost chemoprevention. These studies are an important step toward precision lung cancer chemoprevention in high-risk populations and they are on the leading edge of chemoprevention research.
